中国组织工程研究

中国组织工程研究 ›› 2011, Vol. 15 ›› Issue (51): 9527-9530.doi: 10.3969/j.issn.1673-8225.2011.51.007

• 细胞外基质材料 extracellular matrix materials • 上一篇    下一篇

新型抗钙化牛颈静脉管道材料的体外细胞毒性评价

林  曦1，张卫达1，张宏斌2，李  杰1，王晓莉1   

  1. 解放军广州军区广州总医院，1心血管外科；2医学实验科，广东省广州市  510010
  • 收稿日期:2011-06-04 修回日期:2011-08-07 出版日期:2011-12-17 发布日期:2011-12-17
  • 通讯作者: 张卫达，主任医师，解放军广州军区广州总医院心血管外科，广东省广州市 510010 xzwkzx@ 163.com
  • 作者简介:林曦★，男，1981年生，湖南省衡阳市人，汉族，硕士，主治医师，主要从事先心病的外科治疗。 linxi_military@ hotmail.com
  • 基金资助:

    广东省科技计划项目(2007B031001008)。

In vitro cytotoxicity evaluation of a new type anticalcification bovine jugular venous conduit

Lin Xi1, Zhang Wei-da1, Zhang Hong-bin2, Li Jie1, Wang Xiao-li1   

  1. 1Department of Cardiovascular Surgery, 2Department of Medical Research, Guangzhou General Hospital of Guangzhou Military Command of Chinese PLA, Guangzhou  510010, Guangdong Province, China
  • Received:2011-06-04 Revised:2011-08-07 Online:2011-12-17 Published:2011-12-17
  • Contact: Zhang Wei-da, Chief physician, Department of Cardiovascular Surgery, Guangzhou General Hospital of Guangzhou Military Command of Chinese PLA, Guangzhou 510010, Guangdong Province, China xzwkzx@163.com
  • About author:Lin Xi★, Master, Attending physician, Department of Cardiovascular Surgery, Guangzhou General Hospital of Guangzhou Military Command of Chinese PLA, Guangzhou 510010, Guangdong Province, China linxi_military@ hotmail.com
  • Supported by:

    Science and Technology Planning Projects of Guangdong Province, No. 2007B031001008*

PDF

351

被引次数

2

摘要：

背景：Triton X-100、环氧氯丙烷联合改性处理戊二醛固定的牛颈静脉管道是一种新型抗钙化右心管道材料，其生物相容性方面的研究较少。
目的：评价新型抗钙化牛颈静脉管道的体外细胞毒性。
方法：通过CCK-8法检测新型抗钙化牛颈静脉管道(实验组)及单纯戊二醛处理牛颈静脉管道材料浸提液(对照组)对L-929小鼠成纤维细胞的毒性作用，以第2，4天为检测时间点，计算细胞相对增殖率、对材料毒性进行分级。
结果与结论：CCK-8法细胞毒性试验显示新型抗钙化牛颈静脉管道材料浸提液第2，4天L-929细胞增殖率均在85%以上，毒性分级为1级，无细胞毒性，且显著优于对照组(P < 0.05)。提示经戊二醛、Triton X-100、环氧氯丙烷联合处理制备的新型抗钙化牛颈静脉管道材料无细胞毒性。

关键词: 牛颈静脉管道, Triton X-100, 环氧氯丙烷, 细胞毒性, 生物相容性

Abstract:

BACKGROUND: Triton X-100 and epoxy chloropropane modification with glutaraldehyde-treated bovine jugular venous conduit is a new type anticalcification valved conduit for right ventricular outflow tract reconstruction. There are few reports on the biocompatibility research.
OBJECTIVE: To evaluate the cytotoxicity of the new type anticalcification bovine jugular venous conduit in vitro.
METHODS: The cytotoxicity of the new type anticalcification bovine jugular venous conduit (experimental group) and only glutaraldehyde treated bovine jugular venous conduit extracts (control group) was detected by CCK-8. The relative growth rate was calculated and the toxicity was graded at days 2 and 4.
RESULTS AND CONCLUSION: CCK-8 test results showed that the relative growth rate of the experimental group was more than 85%. The toxicity grade was 1, and there was non-cytotoxicity, which were significantly better than those in the control group (P < 0.05). It was indicated that Triton X-100 and epoxy chloropropane modification with glutaraldehyde-treated bovine jugular venous conduit had no cytotoxicity and should be a safe implanted material.

中图分类号: